Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Certara Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Certara Inc (CERT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
7
Publicly traded peers
Peer Group Market Share
9.03 %
vs 10.40 % a year ago
Revenue Growth Y/Y
-10.81 %
Peers: 4.25 %
Net Margin
-59.26 %
Peers: -11.57 %

Key Findings: Certara Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 408M vs 3,966M combined for tracked competitors (9.3% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-8.7% annualized vs trailing 12 months), vs decelerating (-5.3%) for its tracked peer group.
  • Growth: Certara Inc generated -10.8% revenue growth year over year in Q2 2026, vs 4.3% for its tracked competitors combined.
  • Profitability: Its -59.3% net margin compares with -11.6% for the peer group.
  • Scale: Certara Inc ranks #109 of 259 companies by market capitalization in the Software & Programming industry, holding 0.0% of industry market cap.
  • Peer revenue share: Certara Inc accounted for 9.0% of combined revenue among its tracked peer group, down from 10.4% a year earlier.
  • Peer differentiation: Revenue per employee of $0.26M compares with $0.25M for the peer group (1.0x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

CERT Sales vs. its Competitors, Q2 2026

Certara Inc reported revenue contraction of 10.81 % year on year in Q2 2026, below its competitors' combined revenue growth of 4.25 %.

With a net margin of -59.26 %, Certara Inc reported lower profitability than its competitors (-11.57 %).

Certara Inc generated 9.03 % of the combined sales of its peer group, down from 10.40 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CERT/competitors
https://api.csimarket.com/api/v1/companies/CERT/relationships
https://api.csimarket.com/api/v1/companies/CERT/similar
Programmatic access for models, analytics, and integration workflows.

Certara Inc vs. its Competitors, Q2 2026

Revenue growth, year on year

Certara Inc -10.8 %
Competitors combined +4.3 %

Net margin

Certara Inc -59.3 %
Competitors combined -11.6 %

Revenue run-rate vs trailing 12 months

Certara Inc -8.7 %
Competitors combined -5.3 %

TTM net margin

Certara Inc -16.9 %
Competitors combined -7.8 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Certara Inc and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Certara Inc $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
High-Confidence Competitors (3) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Similar-Size Competitors (7) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Similar Growth & Profitability (5) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Certara Inc's competitor groups requires a Commercial License.

For context: the Software & Programming industry grew revenue 16.0% year over year, combined, vs -10.8% for Certara Inc. Certara Inc's share of combined industry revenue moved from 0.04% to 0.03%, a loss of 0.01 percentage points.

Certara Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Certara Inc No Yes No No
Competitors combined (7) 43% 86% 29% 0%
High-Confidence Competitors (4) 75% 75% 25% 0%
Similar-Size Competitors (10) 60% 70% 40% 22%
Similar Growth & Profitability (8) 62.50 % (5 of 8) 50.00 % (4 of 8) 0.00 % (0 of 8) 28.60 % (2 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

9%market share
  • Certara Inc9.0%
  • Competitors combined91.0%

Share of combined quarterly revenue of Certara Inc and its 7 tracked competitors.

See Certara Inc's full market share breakdown »

CERT Stock Performance relative to its Competitors

CERT Competitors (weighted) Percent change over the selected range

Certara Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
85.7%beat U.S.A. 500
Competitors Combined
(6 of 7)
75%beat U.S.A. 500
High-Confidence
(3 of 4)
0%beat U.S.A. 500
Similar-Size
(0 of 10)
33.3%beat U.S.A. 500
Similar Growth & Profitability
(2 of 6)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Certara Inc -21.30 % Underperformed
Competitors combined (7) 40.4% 63.2%
High-Confidence Competitors (4) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (6) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Certara Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

CERT Stock Performance relative to High-Confidence Competitors

CERT High-Confidence Competitors (equal-weighted, 4) Percent change over the selected range

CERT Stock Performance relative to Similar-Size Competitors

CERT Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

CERT Stock Performance relative to Similar Growth & Profitability Competitors

CERT Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 Abcellera Biologics Inc 282.9% Outperformed
2 Bruker Corporation 282.9% Outperformed
3 Schrodinger Inc 282.9% Outperformed
4 908 Devices inc 282.9% Outperformed
5 Simulations Plus Inc 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Certara Inc's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Certara Inc's Comment on Competition and Industry Peers

The biosimulation products and related services market in the biopharmaceutical industry is competitive and fragmented, with participants varying in size, capabilities, and scope. Some industry players continue to rely on traditional research methods rather than utilizing modeling, simulation, artificial intelligence, dataflow, and analytics platforms. Key competitive factors include model functionality and quality, the range of molecular types and therapeutic areas supported, regulatory acceptance, ease of use, drug development experience, brand reputation, cost, and integration capabilities. The company competes favorably based on these factors and faces significant barriers to new entrants due to the required investment in validated models, software, and model-informed drug development (MIDD) expertise. Competitors in the biosimulation software market include Mathworks, Dassault Systemes, Ansys, Simulations Plus, NONMEM (a division of ICON), as well as open-source solutions such as R and PK-Sim, and internally developed software by biopharmaceutical companies.

Publicly Traded Peers of Certara Inc

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Certara Inc 1,433.20 408.45 -69.00 1,576
Ansys Inc 32,985.94 2,583.10 592.78 6,200
Icon Plc 13,591.92 8,251.34 229.34 40,100
Bruker Corporation 9,674.10 3,498.90 -64.50 11,085
Abcellera Biologics Inc 4,445.86 66.17 -164.66 562
Schrodinger Inc 2,287.48 259.03 -54.33 850
SUBTOTAL 65,233.72 15,208.85 443.08 60,758
2 more competitors available

Sign in to see all competitors of Certara Inc .

Sources: Certara Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Certara Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Certara Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
ICON Named by the company 85% 2022 to 2026 3
Schrodinger Named by the company 85% 2022 to 2026 3
Ansys Named by the company 85% 2022 to 2026 3
Simulations Plus Named by the company 85% 2022 to 2026 3
Metrum Research Group Named by the company 85% 2022 to 2026 3
NONMEM Named by the company 85% 2022 to 2026 3
Mathworks Named by the company 85% 2022 to 2026 3
Dassault Systemes Named by the company 85% 2022 to 2026 3
PK-Sim Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Certara Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Certara Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Certara Inc Reportable 100.00 % - -
Ansys Inc Reportable 100.00 % - -
Bruker Corporation BSI CALID 38.44 % BSI Nano 29.90 % BSI BioSpin 24.00 %
Schrodinger Inc Software 60.70 % Drug discovery 39.30 % -
Simulations Plus Inc Software 57.59 % Software 57.59 % Services 42.38 %

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Certara Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Certara Inc 1,433 259,169 -43,782
Ansys Inc 32,986 416,628 95,610
Icon Plc 13,592 205,769 5,719
Bruker Corporation 9,674 315,643 -5,819
Abcellera Biologics Inc 4,446 117,747 -292,982
Schrodinger Inc 2,287 304,747 -63,924
PEERS TOTAL 63,801 250,083 8,653
2 more Peers available

Sign in to see all peers for Certara Inc .

Certara Inc's Geographic Revenue Exposure vs Peers

Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.
Company Largest Market 2nd Market 3rd Market
Certara Inc Americas 66.59 % EMEA 22.19 % Asia Pacific 11.21 %
Ansys Inc United States 43.59 % EMEA 16.61 % Other international 10.55 %
Icon Plc Ireland 38.58 % United States 30.60 % Rest of Europe 19.28 %
Bruker Corporation Europe excluding Germany 31.47 % US 26.97 % Asia Pacific excluding China 16.37 %
Schrodinger Inc United States 53.61 % EMEA 34.43 % APAC 11.39 %
908 Devices inc US 82.27 % EMEA 8.76 % Americas other 8.34 %

Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.

1 more Peers available

Sign in to see all peers for Certara Inc .

Certara Inc's Position in Industry Market Structure

Market-capitalization share and concentration across all 235 companies in Certara Inc's industry classification, broader than the peer set above. Market cap in millions of $.

Certara Inc ranks #109 of 235 companies by market capitalization in its industry, holding 0.02 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 2,652, indicating a highly concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Microsoft Corporation 3,767,678 50.21 %
2 Palantir Technologies Inc 480,175 6.40 %
3 Oracle Corporation 389,514 5.19 %
4 Sap Se 275,412 3.67 %
5 Crowdstrike Holdings Inc 1,234 5.2%
6 Shopify Inc 1,234 5.2%
7 Salesforce Inc 1,234 5.2%
8 Full Truck Alliance Co Ltd 1,234 5.2%
9 Servicenow Inc 1,234 5.2%
10 Cloudflare Inc 1,234 5.2%
109 Certara Inc 1,433 0.02 %
Full Industry Market Structure

Market cap and industry share for the rest of Certara Inc's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-29.

Certara Inc's Same-Size Peers & Stock Performance

Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.
Rank Company Market Cap TTM Return 3M Momentum Beta Sharpe (1Y)
104 Nayax Ltd 1,613 -4.90 % -38.14 % 0.64 0.05
105 C3 ai Inc 1,603 -39.67 % 11.42 % 2.04 -0.63
106 Opera Ltd 1,579 -7.49 % -15.24 % 1.57 0.00
107 Lightspeed Commerce Inc 1,466 -17.14 % -9.97 % 1.41 -0.27
108 Evercommerce Inc 1,234 12.3% 4.5% 1.10 0.80
109 Certara Inc 1,433 -21.31 % 30.22 % 1.02 -0.16
110 Alkami Technology Inc 1,234 12.3% 4.5% 1.10 0.80
111 Vertex Inc 1,234 12.3% 4.5% 1.10 0.80
112 Bigbear ai Holdings Inc 1,234 12.3% 4.5% 1.10 0.80
113 Sprinklr Inc 1,234 12.3% 4.5% 1.10 0.80
114 Pagerduty Inc 1,234 12.3% 4.5% 1.10 0.80
Full Same-Size Peer Performance

Market cap, return, momentum, beta and Sharpe ratio for the rest of Certara Inc's same-size peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-29. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.

Certara Inc's Profitability & Cost Structure

Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Software & Programming industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (343 companies). See the full Software & Programming industry profitability benchmarks.
Metric Company Industry Difference
Gross Margin 63.42 % 64.28 % (avg) -0.9 pp
Operating Margin 1.54 % industry median +4.3 pp
EBITDA Margin 16.46 % 2.53 % (avg) +13.9 pp
Capital Intensity (Capex / Revenue) 6.93 % 4.79 % (avg) +2.1 pp

Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.

Certara Inc's Valuation vs Competitive Position

Valuation multiples vs the Software & Programming industry average (343 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Software & Programming industry valuation benchmarks.
Metric Company Industry Average Difference
P/E - 39.5x -
EV / EBITDA 15.7x 21.7x -5.9x
P/B 0.9x 5.4x -4.5x
Return on Equity -6.71 % industry aggregate -31.91 %
Return on Invested Capital 0.26 % -0.26 % (avg) 0.52 %

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Certara Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 2021202220242025
Revenue Growth -17.32 %8.70 %8.75 %
Operating Margin 4.75 %9.69 %-0.45 %6.68 %
Return on Invested Capital 0.61 %1.27 %-0.07 %1.11 %
P/E ----

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Certara Inc's Strategic Group Map

Every company in Certara Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Certara Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.

Revenue Growth (TTM, %)Operating Margin (%)ICLRSQIMTLSNUANCertara IncRPDKLTRCMRCBRKR

Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.

Certara Inc's BCG Growth-Share Matrix

Relative market share (vs Certara Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.

Question Mark Star Dog Cash Cow Relative Market Share (vs largest competitor) Industry Revenue Growth (%) Certara Inc

Certara Inc falls in the Question Mark quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 11.6% (median, trailing 12 months).

Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Microsoft Corporation alone holds 50% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.

Certara Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry Low Industry HHI of 2,652 (see Industry Market Structure & Concentration above)
Barriers to Entry High (capital intensive) Capital intensity (capex / revenue) of 6.93 % vs industry average 4.79 % (see Profitability & Cost Structure above)
Supplier Power Not covered on this page See Certara Inc's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Certara Inc's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Certara Inc's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective Certara Inc
Harvest
Low Attractiveness
Selective
Harvest
Harvest / Divest

Certara Inc falls in the Medium attractiveness / Medium strength cell: Selective.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Certara Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

No rule matched.

Weaknesses

  • Return on equity 31.9 points below the industry aggregate.
  • Latest-quarter revenue run-rate is decelerating (-8.7% annualized vs trailing 12 months).
  • Underperforming the U.S.A. 500 over the trailing 12 months.
  • Low relative market share vs the industry leader (0.00x).

Opportunities

  • Industry revenue growing at a healthy 11.6% median pace.

Threats

  • Industry dominated by Microsoft Corporation, holding 50.21 % of industry market cap.
  • Tracked peer group's revenue run-rate is broadly decelerating (-5.3% annualized).
  • High capital intensity requires continuous reinvestment just to keep pace with the industry.

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Certara Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Certara Inc 1.25 2.13 0.29 0.27
Ansys Inc - 3.18 0.13 0.33
Icon Plc 0.20 1.10 0.43 0.51
Bruker Corporation 0.18 1.74 0.75 0.56
Abcellera Biologics Inc 2.31 11.85 - 0.05
Schrodinger Inc 1.40 2.84 - 0.39
2 more Peers available

Sign in to see all peers for Certara Inc .

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Certara Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Certara Inc Q2 2026-10.8 %-12.8 %--
Ansys Inc Q1 2025+8.2 %-42.8 %+49.1 %-81.7 %
Icon PlcQ4 2025-0.4 %-0.4 %-69.0 %-69.0 %
Bruker CorporationQ2 2026+5.2 %+1.9 %--
Abcellera Biologics Inc Q2 2026-76.3 %-51.3 %--
Schrodinger Inc Q2 2026+7.5 %+0.5 %--
PEERS TOTAL+0.4 %-4.0 %-81.0 %-87.2 %
2 more Peers available

Sign in to see all peers for Certara Inc .

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Certara Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Certara Inc Q2 2026+2.4 %-16.2 %-39.6 %+13.5 %
Ansys Inc Q1 2025+0.8 %-54.9 %+9.0 %-2.5 %
Icon PlcQ4 2025+4.4 %+4.4 %+3.7 %+3.7 %
Bruker CorporationQ2 2026-3.8 %-4.6 %+35.2 %+19.0 %
Abcellera Biologics Inc Q2 2026---84.0 %-44.3 %
Schrodinger Inc Q2 2026-7.5 %-8.9 %+15.3 %-85.6 %
2 more Peers available

Sign in to see all peers for Certara Inc .

Certara Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Certara Inc ---4.22-
Ansys Inc 7.66%8.77%10.01%3.15-
Icon Plc1.41%1.68%2.49%5.59-
Bruker Corporation---6.411.65
Abcellera Biologics Inc ---3.44-
Schrodinger Inc ---6.43-
2 more Peers available

Sign in to see all peers for Certara Inc .

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Certara Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Certara Inc -3.51-65.531.48
Ansys Inc 55.4512.771.5646.615.34
Icon Plc59.271.65-125.261.48
Bruker Corporation-2.76-104.134.03
Abcellera Biologics Inc -67.18-162.864.96
Schrodinger Inc -8.83-37.546.95
PEERS AVERAGE147.234.2963.333.22
2 more Peers available

Sign in to see all peers for Certara Inc .

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.